Fundraising FoxProofPilot
New York, US · Founded 2014 · Delaware corporation · 5 known investors
Find your way into ProofPilot
Sign up to see every warm intro you have to ProofPilot
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ProofPilot team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ProofPilot is a sponsor-configured clinical trial platform covering the study lifecycle from enrollment forecasting through patient engagement, with tools for recruitment, site training, and participant retention. It serves clinical operations teams at biotechs and large pharma companies, offering a white-labeled, end-to-end alternative to piecing together multiple clinical trial vendors.
Founders & leadership
ProofPilot was founded in 2014 by Lochlan McHale and Matthew Amsden.
Board
Investors · 5
How we know: Big Red Ventures's portfolio page · Not right? Tell us
How we know: First Trust Capital Partners's portfolio page · clinicaltrialsarena.com · Not right? Tell us
How we know: funding news · clinicaltrialsarena.com · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$26.3M disclosed across 4 of 5 rounds · 2014–2025
- $12MSeries BApr 2022 · 2 sources
Mitsui (lead), Excelra, First Trust Capital Partners, Sopris Capital
Source ↗ - Undisclosed amountSeries CApr 2022Source ↗
▶$7.7MraisedSep 2025 · 18 investors · Other TechnologyRule 506(b)
- David EkizianDirector
- Chris VeneziaExecutive Officer, Director
- Jeff KozloffDirector
- Abinav SankarDirector
- Offering amount
- $7.7M
- Amount sold
- $7.7M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.7MraisedAug 2024 · 18 investors · Other TechnologyRule 506(b)
- David EkizianDirector
- Esther DysonDirector
- Chris VeneziaExecutive Officer, Director
- Jeff KozloffDirector
- Abinav SankarDirector
- Offering amount
- $4.7M
- Amount sold
- $4.7M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedNov 2014 · 15 investors · Other TechnologyRule 506(b)
- Lochlan McHaleExecutive Officer, Director
- Matthew AmsdenExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.9M
- Minimum investment
- $5K
- Proceeds to insiders
- $154K
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through ProofPilot went on to found or lead other companies.
Frequently asked questions
- What does ProofPilot do?
- ProofPilot is a sponsor-configured clinical trial platform covering the study lifecycle from enrollment forecasting through patient engagement, with tools for recruitment, site training, and participant retention. It serves clinical operations teams at biotechs and large pharma companies, offering a white-labeled, end-to-end alternative to piecing together multiple clinical trial vendors.
- Who founded ProofPilot?
- ProofPilot was founded by Lochlan McHale, Matthew Amsden in 2014.
- Who are ProofPilot's investors?
- ProofPilot's investors include Big Red Ventures, First Trust Capital Partners, Mitsui & Co.
- How much funding has ProofPilot raised?
- ProofPilot has disclosed $26.3M raised across 4 of its 5 known rounds.
- Where is ProofPilot headquartered?
- ProofPilot is headquartered in New York, US.